Human TNF RI/TNFRSF1A Quantikine ELISA Kit | R&D Systems DRT100 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

R&D Systems

product type :

ELISA/assay

product name :

Human TNF RI/TNFRSF1A Quantikine ELISA Kit

catalog :

DRT100

quantity :

1 Kit (also 1 Pack (50 Plates), 1 Pack (6 Plates))

price :

655 USD

citations: 86

Reference
Iacovacci J, Serafini M, Avuzzi B, Badenchini F, Cicchetti A, Devecchi A, et al. Intestinal microbiota composition is predictive of radiotherapy-induced acute gastrointestinal toxicity in prostate cancer patients. EBioMedicine. 2024;106:105246 pubmed publisher
Hassan L, Bedir A, Kraus F, Ostheimer C, Vordermark D, Mikolajczyk R, et al. Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study. Cancers (Basel). 2024;16: pubmed publisher
Morales T, Stamper C, Brenner L. High molar ratios of tumor necrosis factor α (TNF α) soluble receptors I and II to the TNF ligand in human plasma from male veterans with comorbid posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Eur J Psychiatry. 2023;37:141-148 pubmed publisher
Nakanuma S, Gabata R, Okazaki M, Seki A, Hosokawa K, Yokoyama T, et al. Hemophagocytic Lymphohistiocytosis With Elevated Cytokines Related to Macrophage Activation After Liver Transplantation for Autoimmune Hepatitis: A Case Report. Transplant Proc. 2023;55:1946-1950 pubmed publisher
Salai K, Wu L, Chong J, Chai Y, Gyanwali B, Robert C, et al. Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease. Biomolecules. 2023;13: pubmed publisher
Gohda T, Murakoshi M, Suzuki Y, Hiki M, Naito T, Takahashi K, et al. Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients. PLoS ONE. 2022;17:e0275745 pubmed publisher
Hinton T, Karnak D, Tang M, Jiang R, Luo Y, Boonstra P, et al. Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis. Transl Oncol. 2022;21:101428 pubmed publisher
Albar Z, Albakri M, Hajjari J, Karnib M, Janus S, Al Kindi S. Inflammatory Markers and Risk of Heart Failure With Reduced to Preserved Ejection Fraction. Am J Cardiol. 2022;167:68-75 pubmed publisher
Takao T, Yanagisawa H, Suka M, Yoshida Y, Onishi Y, Tahara T, et al. Synergistic association of the copper/zinc ratio under inflammatory conditions with diabetic kidney disease in patients with type 2 diabetes: The Asahi Diabetes Complications Study. J Diabetes Investig. 2022;13:299-307 pubmed publisher
Wardzyńska A, Pawełczyk M, Rywaniak J, Makowska J, Jamroz Brzeska J, Kowalski M. Circulating miRNA expression in asthmatics is age-related and associated with clinical asthma parameters, respiratory function and systemic inflammation. Respir Res. 2021;22:177 pubmed publisher
Oshima M, Hara A, Toyama T, Jun M, Pollock C, Jardine M, et al. Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor. Kidney Int Rep. 2021;6:284-295 pubmed publisher
Cousins M, Morris E, Maurino C, Devasia T, Karnak D, Ray D, et al. TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy. Transl Oncol. 2021;14:100950 pubmed publisher
Cezar R, Winter A, Desigaud D, Pastore M, Kundura L, Dupuy A, et al. Identification of distinct immune activation profiles in adult humans. Sci Rep. 2020;10:20824 pubmed publisher
Hassan L, Medenwald D, Tiller D, Kluttig A, Ludwig Kraus B, Kraus F, et al. The association between change of soluble tumor necrosis factor receptor R1 (sTNF-R1) measurements and cardiovascular and all-cause mortality-Results from the population-based (Cardiovascular Disease, Living and Ageing in Halle) CARLA study 2002-2016. PLoS ONE. 2020;15:e0241213 pubmed publisher
Roth D, Haley W, Sheehan O, Huang J, Rhodes J, Durda P, et al. The transition to family caregiving and its effect on biomarkers of inflammation. Proc Natl Acad Sci U S A. 2020;117:16258-16263 pubmed publisher
Murakoshi M, Gohda T, Suzuki Y. Circulating Tumor Necrosis Factor Receptors: A Potential Biomarker for the Progression of Diabetic Kidney Disease. Int J Mol Sci. 2020;21: pubmed publisher
Baker J, Wolfson J, Peterson T, Mooberry M, Gissel M, Mystakelis H, et al. Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial. Open Forum Infect Dis. 2020;7:ofaa026 pubmed publisher
Camargo J, Pallikkuth S, Moroz I, Natori Y, Alcaide M, Rodriguez A, et al. Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients. Kidney Int Rep. 2019;4:1705-1716 pubmed publisher
Scurt F, Menne J, Brandt S, Bernhardt A, Mertens P, Haller H, et al. Systemic Inflammation Precedes Microalbuminuria in Diabetes. Kidney Int Rep. 2019;4:1373-1386 pubmed publisher
Uwada J, Yazawa T, Nakazawa H, Mikami D, Krug S, Fromm M, et al. Store-operated calcium entry (SOCE) contributes to phosphorylation of p38 MAPK and suppression of TNF-α signalling in the intestinal epithelial cells. Cell Signal. 2019;63:109358 pubmed publisher
Ohta N, Yasudo H, Mizutani M, Matsushige T, Fukano R, Kittaka S, et al. Serum soluble ST2 as a marker of renal scar in pediatric upper urinary tract infection. Cytokine. 2019;120:258-263 pubmed publisher
Loh K, Tooze J, Nicklas B, Kritchevsky S, Williamson J, Ellis L, et al. Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. J Geriatr Oncol. 2019;: pubmed publisher
Grzanka R, Damasiewicz Bodzek A, Kasperska Zajac A. Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria. Allergy Asthma Clin Immunol. 2019;15:15 pubmed publisher
Yogasundaram H, Nikhanj A, Putko B, Boutin M, Jain Ghai S, Khan A, et al. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018;7:e009098 pubmed publisher
Foo S, Chen W, Chan Y, Lee W, Lee S, Cheng G, et al. Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight. 2018;3: pubmed publisher
Matsukiyo Y, Nagai H, Matsui T, Igarashi Y. Host Immunological Effects of Partial Splenic Embolization in Patients with Liver Cirrhosis. J Immunol Res. 2018;2018:1746391 pubmed publisher
Sharaf R, Lee G, Sun X, Etemad B, Aboukhater L, Hu Z, et al. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest. 2018;128:4074-4085 pubmed publisher
Vande Casteele N, Oyamada J, Shimizu C, Best B, Capparelli E, Tremoulet A, et al. Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease. Clin Pharmacokinet. 2018;57:1593-1601 pubmed publisher
Holdbrooks A, Britain C, Bellis S. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor. J Biol Chem. 2018;293:1610-1622 pubmed publisher
Belury M, Bowman E, Gabriel J, Snyder B, Kulkarni M, Palettas M, et al. Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV. Pathog Immun. 2017;2:376-403 pubmed publisher
de Armas L, Pallikkuth S, George V, Rinaldi S, Pahwa R, Arheart K, et al. Reevaluation of immune activation in the era of cART and an aging HIV-infected population. JCI Insight. 2017;2: pubmed publisher
Mizutani M, Hasegawa S, Matsushige T, Ohta N, Kittaka S, Hoshide M, et al. Distinctive inflammatory profile between acute focal bacterial nephritis and acute pyelonephritis in children. Cytokine. 2017;99:24-29 pubmed publisher
Uwada J, Yazawa T, Islam M, Khan M, Krug S, Fromm M, et al. Activation of muscarinic receptors prevents TNF-?-mediated intestinal epithelial barrier disruption through p38 MAPK. Cell Signal. 2017;35:188-196 pubmed publisher
Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, et al. Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis. Sci Rep. 2017;7:43520 pubmed publisher
Williams E, Baines K, Berthon B, Wood L. Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial. Nutrients. 2017;9: pubmed publisher
Kulkarni M, Bowman E, Gabriel J, Amburgy T, Mayne E, Zidar D, et al. Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2016;3:ofw224 pubmed publisher
Cauley J, Kassem A, Lane N, Thorson S. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr. 2016;16:213 pubmed
Gibellini L, De Biasi S, Bianchini E, Bartolomeo R, Fabiano A, Manfredini M, et al. Anti-TNF-? Drugs Differently Affect the TNF?-sTNFR System and Monocyte Subsets in Patients with Psoriasis. PLoS ONE. 2016;11:e0167757 pubmed publisher
Kim H, Lee J, An J, Kim J, Lim W, Seo J, et al. Soluble Tumor Necrosis Factor Receptors and Arterial Stiffness in Patients With Coronary Atherosclerosis. Am J Hypertens. 2017;30:313-318 pubmed publisher
Eng G, Bouchelouche P, Bartels E, Bliddal H, Bendtzen K, Stoltenberg M. Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study. PLoS ONE. 2016;11:e0162316 pubmed publisher
Pedigo C, Ducasa G, Leclercq F, Sloan A, Mitrofanova A, Hashmi T, et al. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury. J Clin Invest. 2016;126:3336-50 pubmed publisher
Cauley J, Barbour K, Harrison S, Cloonan Y, Danielson M, Ensrud K, et al. Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the Osteoporotic Fractures in Men (MrOS). J Bone Miner Res. 2016;31:2129-2138 pubmed publisher
Ouyang S, Li W, Liu Z, Li Y, Li S, Wu J. Association between serum soluble tumor necrosis factor-? receptors and early childhood obesity. Endocr J. 2016;63:581-7 pubmed publisher
Ghislain M, Bastard J, Meyer L, Capeau J, Fellahi S, GÃ©rard L, et al. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities. PLoS ONE. 2015;10:e0144317 pubmed publisher
Jarrett O, Brady K, Modur S, Plants J, Landay A, Ghassemi M, et al. T. vaginalis Infection Is Associated with Increased IL-8 and TNFr1 Levels but with the Absence of CD38 and HLADR Activation in the Cervix of ESN. PLoS ONE. 2015;10:e0130146 pubmed publisher
Hayslip J, Dressler E, Weiss H, Taylor T, Chambers M, Noel T, et al. Plasma TNF-Î± and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study. PLoS ONE. 2015;10:e0124988 pubmed publisher
Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, et al. Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy. PLoS ONE. 2015;10:e0122212 pubmed publisher
Duvillard L, Ortega Deballon P, Bourredjem A, Scherrer M, Mantion G, Delhorme J, et al. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer. BMC Cancer. 2014;14:912 pubmed publisher
Pisetsky D, Trace S, Brownley K, Hamer R, Zucker N, Roux Lombard P, et al. The expression of cytokines and chemokines in the blood of patients with severe weight loss from anorexia nervosa: an exploratory study. Cytokine. 2014;69:110-5 pubmed publisher
Putko B, Wang Z, Lo J, Anderson T, Becher H, Dyck J, et al. Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology. PLoS ONE. 2014;9:e99495 pubmed publisher
Broch K, Askevold E, Gjertsen E, Ueland T, Yndestad A, Godang K, et al. The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial. PLoS ONE. 2014;9:e89732 pubmed publisher
Funderburg N, Andrade A, Chan E, Rosenkranz S, Lu D, Clagett B, et al. Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine. PLoS ONE. 2013;8:e83514 pubmed publisher
Wong J, Muthuswamy R, Bartlett D, Kalinski P. IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients. Oncoimmunology. 2013;2:e26245 pubmed
Lee J, Gohda T, Walker W, Skupien J, Smiles A, Holak R, et al. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS ONE. 2013;8:e58007 pubmed publisher
Shimizu M, Yachie A. Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages. Cytokine. 2012;60:226-32 pubmed publisher
Grote V, Kaaks R, Nieters A, Tjønneland A, Halkjær J, Overvad K, et al. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer. 2012;106:1866-74 pubmed publisher
Barbour K, Boudreau R, Danielson M, Youk A, Wactawski Wende J, Greep N, et al. Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res. 2012;27:1167-76 pubmed publisher
Lee N, Wong C, Chan P, Chan M, Wong R, Lun S, et al. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLoS ONE. 2011;6:e26050 pubmed publisher
Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, et al. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease. Mol Neurodegener. 2011;6:69 pubmed publisher
Kawut S, Barr R, Johnson W, Chahal H, Tandri H, Jain A, et al. Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study. Biomarkers. 2010;15:731-8 pubmed publisher
Johansson A, Nandakumar K, Persson A, Olsson I, Hansson M. Secretory lysosome targeting and induced secretion of human soluble TNF-alpha receptor in murine hematopoietic cells in vivo as a principle for immunoregulation in inflammation and malignancy. Exp Hematol. 2009;37:969-78 pubmed publisher
Gombos T, Förhécz Z, Pozsonyi Z, Wallentin S, Papassotiriou J, Kunde J, et al. Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure. Inflamm Res. 2009;58:298-305 pubmed publisher
Vgontzas A, Zoumakis E, Bixler E, Lin H, Collins B, Basta M, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest. 2008;38:585-95 pubmed publisher
Choi S, Kitko C, Braun T, Paczesny S, Yanik G, Mineishi S, et al. Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival. Blood. 2008;112:1539-42 pubmed publisher
Denollet J, Vrints C, Conraads V. Comparing Type D personality and older age as correlates of tumor necrosis factor-alpha dysregulation in chronic heart failure. Brain Behav Immun. 2008;22:736-43 pubmed
Canault M, Leroyer A, Peiretti F, Leseche G, Tedgui A, Bonardo B, et al. Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. Am J Pathol. 2007;171:1713-23 pubmed
Kissel C, Lehmann R, Assmus B, Aicher A, Honold J, Fischer Rasokat U, et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol. 2007;49:2341-9 pubmed
Doucet M, Russell A, Leger B, Debigare R, Joanisse D, Caron M, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:261-9 pubmed
Cauley J, Danielson M, Boudreau R, Forrest K, Zmuda J, Pahor M, et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res. 2007;22:1088-95 pubmed
Corvino C, Mamoni R, Fagundes G, Blotta M. Serum interleukin-18 and soluble tumour necrosis factor receptor 2 are associated with disease severity in patients with paracoccidioidomycosis. Clin Exp Immunol. 2007;147:483-90 pubmed
Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan Vague I, Nalbone G, et al. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res. 2006;312:3969-80 pubmed
Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care. 2006;29:1096-101 pubmed
D Osualdo A, Ferlito F, Prigione I, Obici L, Meini A, Zulian F, et al. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications. Arthritis Rheum. 2006;54:998-1008 pubmed
Bouchama A, Ollivier V, Roberts G, Al Mohanna F, de Prost D, Eldali A, et al. Experimental heatstroke in baboon: analysis of the systemic inflammatory response. Shock. 2005;24:332-5 pubmed
Vergne Salle P, Leger D, Bertin P, Treves R, Beneytout J, Liagre B. Effects of the active metabolite of leflunomide, A77 1726, on cytokine release and the MAPK signalling pathway in human rheumatoid arthritis synoviocytes. Cytokine. 2005;31:335-48 pubmed
Kermarrec N, Selloum S, Plantefeve G, Chosidow D, Paoletti X, Lopez A, et al. Regulation of peritoneal and systemic neutrophil-derived tumor necrosis factor-alpha release in patients with severe peritonitis: role of tumor necrosis factor-alpha converting enzyme cleavage. Crit Care Med. 2005;33:1359-64 pubmed
Parissis J, Adamopoulos S, Karatzas D, Paraskevaidis J, Livanis E, Kremastinos D. Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy. Eur J Cardiovasc Prev Rehabil. 2005;12:164-8 pubmed
Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:411-8 pubmed
Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:276-84 pubmed
Tagawa T, Kozower B, Kanaan S, Daddi N, Muraoka M, Oka T, et al. Gene transfer of tumor necrosis factor inhibitor improves the function of lung allografts. J Thorac Cardiovasc Surg. 2004;127:1558-63 pubmed
McNamara P, Flanagan B, Selby A, Hart C, Smyth R. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J. 2004;23:106-12 pubmed
Lukashevich I, Tikhonov I, Rodas J, Zapata J, Yang Y, Djavani M, et al. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J Virol. 2003;77:1727-37 pubmed
Attanasio R, Brasky K, Robbins S, Jayashankar L, Nash R, Butler T. Age-related autoantibody production in a nonhuman primate model. Clin Exp Immunol. 2001;123:361-5 pubmed
Rooney M, Varsani H, Martin K, Lombard P, Dayer J, Woo P. Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis. Rheumatology (Oxford). 2000;39:432-8 pubmed
Welty Wolf K, Carraway M, Ghio A, Kantrow S, Huang Y, Piantadosi C. Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy. Shock. 2000;13:404-9 pubmed
Otterness I, Swindell A, Zimmerer R, Poole A, Ionescu M, Weiner E. An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis Cartilage. 2000;8:180-5 pubmed

product information

master code :

DRT100

SKU :

DRT100

product name :

Human TNF RI/TNFRSF1A Quantikine ELISA Kit

unit size :

1 Kit (also 1 Pack (50 Plates), 1 Pack (6 Plates))

description :

The Human TNF RI/TNFRSF1A Quantikine ELISA Kit from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human TNF RI/TNFRSF1A in cell culture supernates (200 ul), serum (20 ul), edta plasma (20 ul), heparin plasma (20 ul), citrate plasma (20 ul), urine (20 ul).

target :

TNF RI/TNFRSF1A

category :

ELISAs

species :

Human

specificity :

Natural and recombinant human sTNF RI

gene symbol :

TNFRSF1A

kit type :

Solid Phase Sandwich ELISA

assay length :

4.5 hours

elisaSampleTypes :

Cell Culture Supernates (200 uL), Serum (20 uL), EDTA Plasma (20 uL), Heparin Plasma (20 uL), Citrate Plasma (20 uL), Urine (20 uL)

elisaSensitivity :

1.2 pg/mL

elisaRange :

7.80 - 500 pg/mL

top caption :

Human TNF RI/TNFRSF1A ELISA Calibrator Diluent RD5-5 Standard Curve

applications :

ELISA

USD :

655 USD

product details :

The Quantikine Human sTNF RI Immunoassay is a 4.5 hour solid phase ELISA designed to measure sTNF RI in cell culture supernates, serum, plasma, and urine. It contains E. coli -expressed recombinant human sTNF RI, as well as antibodies raised against this polypeptide. The recombinant protein represents the non-glycosylated, N-terminal methionyl form of the naturally occurring human soluble Type I receptor for TNF with an apparent molecular weight of approximately 18.6 kDa. This immunoassay has been shown to accurately quantitate the recombinant sTNF RI. Results obtained on samples containing natural sTNF RI showed linear curves that were parallel to the standard curves obtained using the Quantikine kit standards. These results indicate that this kit can be used to determine relative mass values of natural sTNF RI. Since the measurement of human sTNF RI by this immunoassay is relatively insensitive to added TNF-alpha or TNF-beta, it is probable that this measurement corresponds to the total amount of the soluble receptor present in samples (i.e. the total amount of free receptor plus the total amount of receptor bound to TNF).

alt names :

CD120a, CD120a antigen, FPF, p55, p55-R, p60, TNFARMGC19588, TNF-R, TNF-R1, TNFR1TBP1, TNFR55, TNF-R55, TNFR60, TNFRI, TNF-RI, TNF-R-I, TNFR-I, TNFRSF1A, tumor necrosis factor binding protein 1, Tumor necrosis factor receptor 1, tumor necrosis factor receptor 1A isoform beta, tumor necrosis factor receptor superfamily member 1A, tumor necrosis factor receptor superfamily, member 1A, tumor necrosis factor receptor type 1, Tumor necrosis factor receptor type I, tumor necrosis factor-alpha receptor

storage :

Store the unopened product at 2 - 8 ░C. Do not use past expiration date.